Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways

IntroductionThe gut microbiota plays a pivotal role in influencing host health, through the production of metabolites and other key signalling molecules. While the impact of specific metabolites or taxa on host cells is well-documented, the broader impact of a disrupted microbiota on immune homeosta...

Full description

Saved in:
Bibliographic Details
Main Authors: Jemma J. Taitz, Jian Tan, Duan Ni, Camille Potier-Villette, Georges Grau, Ralph Nanan, Laurence Macia
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1493991/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841554009128697856
author Jemma J. Taitz
Jemma J. Taitz
Jian Tan
Jian Tan
Duan Ni
Duan Ni
Camille Potier-Villette
Camille Potier-Villette
Georges Grau
Georges Grau
Ralph Nanan
Ralph Nanan
Ralph Nanan
Laurence Macia
Laurence Macia
Laurence Macia
author_facet Jemma J. Taitz
Jemma J. Taitz
Jian Tan
Jian Tan
Duan Ni
Duan Ni
Camille Potier-Villette
Camille Potier-Villette
Georges Grau
Georges Grau
Ralph Nanan
Ralph Nanan
Ralph Nanan
Laurence Macia
Laurence Macia
Laurence Macia
author_sort Jemma J. Taitz
collection DOAJ
description IntroductionThe gut microbiota plays a pivotal role in influencing host health, through the production of metabolites and other key signalling molecules. While the impact of specific metabolites or taxa on host cells is well-documented, the broader impact of a disrupted microbiota on immune homeostasis is less understood, which is particularly important in the context of the increasing overuse of antibiotics.MethodsFemale C57BL/6 mice were gavaged twice daily for four weeks with Vancomycin, Polymyxin B, or PBS (control). Caecal microbiota composition was assessed via 16S rRNA sequencing and caecal metabolites were quantified with NMR spectroscopy. Immune profiles of spleen and mesenteric lymph nodes (MLNs) were assessed by flow cytometry, and splenocytes assessed for ex vivo cytokine production. A generalised additive model approach was used to examine the relationship between global antibiotic consumption and IBD incidence.ResultsAntibiotics significantly altered gut microbiota composition, reducing alpha-diversity. Acetate and butyrate were significantly reduced in antibiotic groups, while propionate and succinate increased in Vancomycin and PmB-treated mice, respectively. The MLNs and spleen showed changes only to DC numbers. Splenocytes from antibiotic-treated mice stimulated ex vivo exhibited increased production of TNF. Epidemiological analysis revealed a positive correlation between global antibiotic consumption and IBD incidence.DiscussionOur findings demonstrate that antibiotic-mediated dysbiosis results in significantly altered short-chain fatty acid levels but immune homeostasis in spleen and MLNs at steady state is mostly preserved. Non-specific activation of splenocytes ex vivo, however, revealed mice with perturbed microbiota had significantly elevated production of TNF. Thus, this highlights antibiotic-mediated disruption of the gut microbiota may program the host towards dysregulated immune responses, predisposing to the development of TNF-associated autoimmune or chronic inflammatory disease.
format Article
id doaj-art-fdb507fb008146e481b26382ac99cca2
institution Kabale University
issn 1664-3224
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj-art-fdb507fb008146e481b26382ac99cca22025-01-09T05:10:21ZengFrontiers Media S.A.Frontiers in Immunology1664-32242025-01-011510.3389/fimmu.2024.14939911493991Antibiotic-mediated dysbiosis leads to activation of inflammatory pathwaysJemma J. Taitz0Jemma J. Taitz1Jian Tan2Jian Tan3Duan Ni4Duan Ni5Camille Potier-Villette6Camille Potier-Villette7Georges Grau8Georges Grau9Ralph Nanan10Ralph Nanan11Ralph Nanan12Laurence Macia13Laurence Macia14Laurence Macia15Charles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaVascular Immunology Unit, Discipline of Pathology, School of Medical Sciences, University of Sydney, Sydney, NSW, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaSydney Medical School Nepean, The University of Sydney, Sydney, NSW, AustraliaCharles Perkins Centre, The University of Sydney, Sydney, NSW, AustraliaSchool of Medical Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaSydney Medical School Nepean, The University of Sydney, Sydney, NSW, AustraliaIntroductionThe gut microbiota plays a pivotal role in influencing host health, through the production of metabolites and other key signalling molecules. While the impact of specific metabolites or taxa on host cells is well-documented, the broader impact of a disrupted microbiota on immune homeostasis is less understood, which is particularly important in the context of the increasing overuse of antibiotics.MethodsFemale C57BL/6 mice were gavaged twice daily for four weeks with Vancomycin, Polymyxin B, or PBS (control). Caecal microbiota composition was assessed via 16S rRNA sequencing and caecal metabolites were quantified with NMR spectroscopy. Immune profiles of spleen and mesenteric lymph nodes (MLNs) were assessed by flow cytometry, and splenocytes assessed for ex vivo cytokine production. A generalised additive model approach was used to examine the relationship between global antibiotic consumption and IBD incidence.ResultsAntibiotics significantly altered gut microbiota composition, reducing alpha-diversity. Acetate and butyrate were significantly reduced in antibiotic groups, while propionate and succinate increased in Vancomycin and PmB-treated mice, respectively. The MLNs and spleen showed changes only to DC numbers. Splenocytes from antibiotic-treated mice stimulated ex vivo exhibited increased production of TNF. Epidemiological analysis revealed a positive correlation between global antibiotic consumption and IBD incidence.DiscussionOur findings demonstrate that antibiotic-mediated dysbiosis results in significantly altered short-chain fatty acid levels but immune homeostasis in spleen and MLNs at steady state is mostly preserved. Non-specific activation of splenocytes ex vivo, however, revealed mice with perturbed microbiota had significantly elevated production of TNF. Thus, this highlights antibiotic-mediated disruption of the gut microbiota may program the host towards dysregulated immune responses, predisposing to the development of TNF-associated autoimmune or chronic inflammatory disease.https://www.frontiersin.org/articles/10.3389/fimmu.2024.1493991/fullgut microbiotadysbiosisantibioticsvancomycinPolymyxin BTNF
spellingShingle Jemma J. Taitz
Jemma J. Taitz
Jian Tan
Jian Tan
Duan Ni
Duan Ni
Camille Potier-Villette
Camille Potier-Villette
Georges Grau
Georges Grau
Ralph Nanan
Ralph Nanan
Ralph Nanan
Laurence Macia
Laurence Macia
Laurence Macia
Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
Frontiers in Immunology
gut microbiota
dysbiosis
antibiotics
vancomycin
Polymyxin B
TNF
title Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
title_full Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
title_fullStr Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
title_full_unstemmed Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
title_short Antibiotic-mediated dysbiosis leads to activation of inflammatory pathways
title_sort antibiotic mediated dysbiosis leads to activation of inflammatory pathways
topic gut microbiota
dysbiosis
antibiotics
vancomycin
Polymyxin B
TNF
url https://www.frontiersin.org/articles/10.3389/fimmu.2024.1493991/full
work_keys_str_mv AT jemmajtaitz antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT jemmajtaitz antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT jiantan antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT jiantan antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT duanni antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT duanni antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT camillepotiervillette antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT camillepotiervillette antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT georgesgrau antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT georgesgrau antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT ralphnanan antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT ralphnanan antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT ralphnanan antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT laurencemacia antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT laurencemacia antibioticmediateddysbiosisleadstoactivationofinflammatorypathways
AT laurencemacia antibioticmediateddysbiosisleadstoactivationofinflammatorypathways